Certain reprocessed catheters may contain residual particulates that could cause infection, embolism, or thrombosis.
Similar Posts
Generic Drug Development
Information for generic drug development assistance, generic drug approvals, and generic drug regulatory resources.Compounding when Drugs are on FDA’s Drug Shortages List
FDA understands that when a drug is in shortage, patients and health care professionals may look to compounded drugs as an option to get the medication they need.GFA Production (Xiamen) Co., Ltd. Issues Voluntary Nationwide Recall of Easy Care First Aid® Burn Cream and First Aid Kits Due to Microbial Contamination
Xiamen, Fujian, GFA Production (Xiamen) Co., Ltd. is voluntarily recalling one lot of Easy Care first aid® AfterBurn® Cream, 0.9 g single-use packets. The single use packets are sold in boxes of 10 or packaged in certain First Aid kits. This recall is to the consumer level. FDA analysis found the pModel Master Files: Advancing Modeling and Simulation in Generic Drug Development and Regulatory Submissions – 03/13/2025
Model Master Files: Advancing Modeling and Simulation in Generic Drug Development and Regulatory SubmissionsQuesito El Establo Recalls Spanish Cheese (Quesito Colombiano) Because of Possible Health Risk
Quesito El Establo of Salem, NH is recalling all Spanish Cheese (Quesito Colombiano) manufactured in their facility, due to the presence of rodent, rodent activity, and other insanitary conditions during the manufacturing and storage process.FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live). FDA Suspends Biologics License: FDA Safety Communication
On August 22, 2025,the US FDA’s Center for Biologics Evaluation and Research has suspended the biologics license for Valneva Austria GmbH’s Ixchiq (Chikungunya Vaccine, Live). This vaccine was initially approved by FDA under the accelerated approval pathway in November of 2023 for the prevention of